After nearly 25 years, the iconic Ford Bronco is getting revamped and making a comeback with two new additions to the series' family, Dave Pericak, global director of icons at Ford, told Cheddar.

"If you look at SUVs, they're more popular now than they've ever been. In 2019, SUVs had their most sales ever. So, now is the time," he said.

The iconic off-roader's sport model is set to hit the sales floor in the U.S. later this year, according to Pericak, with the two-door and first-ever four-door versions to hit the market next year. Even as the fully gas-powered SUVs draw anticipation, they're not currently part of Ford's push to reduce greenhouse gas emissions.

Pericak said the company will be spending more than $11.5 billion in electrification over the next several years, but noted the initial focus will be on the F-150, Mustang, and Transit. 

The coronavirus pandemic has hit U.S. automakers, including Ford, where deliveries reportedly dropped by a third year-over-year in Q2. Still, Pericak is optimistic that an uptick is coming as economies reopen. 

"I hope that we're going to be coming out of this coronavirus pretty soon. I think we're going to be hitting it at the right time when people have a lot of the pent up demand," he said.

Ford is set to debut the new line of vehicles on July 13. 

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More